Diazoxide

From WikiMD's WELLNESSPEDIA

(Redirected from Mutabase)

Chemical structure of Diazoxide

Diazoxide is a medication primarily used to treat hypoglycemia due to hyperinsulinism, and it is also used as a vasodilator in the management of hypertensive emergencies. It works by inhibiting the release of insulin from the pancreas and by relaxing smooth muscle cells in the blood vessels.

Mechanism of Action[edit]

Diazoxide acts by opening potassium channels in the beta cells of the pancreas, which leads to hyperpolarization of the cell membrane and inhibition of insulin release. This action is beneficial in conditions where there is excessive insulin production, such as congenital hyperinsulinism.

As a vasodilator, diazoxide relaxes the smooth muscle in the peripheral arterioles, leading to a decrease in peripheral vascular resistance and a subsequent drop in blood pressure.

Medical Uses[edit]

Treatment of Hypoglycemia[edit]

Diazoxide is used in the management of hypoglycemia caused by excessive insulin secretion. It is particularly useful in conditions like insulinoma and congenital hyperinsulinism. By reducing insulin secretion, diazoxide helps to maintain normal blood glucose levels.

Hypertensive Emergencies[edit]

In the past, diazoxide was used in the treatment of hypertensive emergencies due to its rapid vasodilatory effects. However, its use in this context has decreased with the availability of newer antihypertensive agents.

Side Effects[edit]

Common side effects of diazoxide include fluid retention, hyperglycemia, and tachycardia. Due to its effects on blood glucose levels, it can cause significant hyperglycemia, especially in patients with diabetes mellitus.

Pharmacokinetics[edit]

Diazoxide is administered orally or intravenously. It is highly protein-bound and has a long half-life, which allows for less frequent dosing. The drug is metabolized in the liver and excreted primarily in the urine.

Related Pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.